A clinical formulation indicated for Erectile Dysfunction. Substance promotes vasodilation within vascular pathways to enhance physiological responsiveness.
A PDE5 inhibitor developed to alleviate erectile dysfunction and intended to manage male sexual health by targeting blood flow to support achieving a firm erection.
Mechanism of Action
It inhibits the PDE5 enzyme, increasing blood flow to the penis during sexual stimulation by relaxing the surrounding smooth muscles and blood vessels.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
4–6 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Uncontrolled hypertension, Allergy to sildenafil
Information for Fildena is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.